MO completes the NJOY acquisition
$Altria(MO)$ MO completes the NJOY acquisition
» $2.75 B acquisition ($2 B debt+cash)
» 1% to 4% increase to Adj. EPS in FY23
» NJOY ACE only FDA approved pod e-vapor product
» MO identified 70k Point of sales for expansion
FY22 US e-cigs sales (statista)
NJOY had a 3% share
Juul had 37%
NJOY PMTA (from year ago)
The FDA issued marketing granted orders to NJOY for its Ace closed e-cigarette device and three accompanying tobacco-flavored e-liquid pods, specifically:
NJOY Ace Device
NJOY Ace Pod Classic Tobacco 2.4%
NJOY Ace Pod Classic Tobacco 5%
NJOY Ace Pod Rich Tobacco 5%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.